secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuronetics, Inc. (STIM)
CIK:        0001227636
Form:       8-K
Filed at:   2025-05-06T23:59:59+00:00
Accession:  0001193125-25-113283
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neuronetics Q1 revenue $32M (+84% YoY); narrows FY guidance; CFO to retire March 2026
--------------------------------------------------------------------------------

- Q1 revenue $32.0M, up 84% YoY driven by Greenbrook acquisition; net loss $(12.7)M vs $(7.9)M
- U.S. clinic revenue $18.7M (post-Greenbrook); NeuroStar system revenue $2.8M (-14%)
- CFO Steve Furlong to retire March 31, 2026; search for successor underway
- Full-year 2025 revenue guidance narrowed to $149M-$155M (prev $145M-$155M)
- Cash $20.2M; expects Q3 2025 cash flow positive; Q2 cash usage <$5M

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1227636/000119312525113283/0001193125-25-113283-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1227636/000119312525113283/d947826d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-113283

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer